전체 프로그램

CGTBiologicstaleGuangzhou Bio-gene Technology C…Phase 1

CDH17 CAR-T (CDH17 CAR-T)

Biliary Tract Cancer; Colorectal Carcinoma · Biliary Tract Cancer

#BiliaryTractCancer#CGT#Phase1#세포유전치료#CAR-T+3

ADCBiologicstaleDualityBio Inc.Phase 3

DB-1303/BNT323 (DB-1303/BNT323)

HER2-positive Breast Cancer · HER2

#HER2#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2

ADCBiologicstaleNational Cancer Institute (NCI)Phase 2

Larotrectinib Sulfate (Larotrectinib Sulfate)

Advanced Lymphoma; Advanced Malignant Solid Neoplasm · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3

효능 ORR 60%임상시험 5상태 RECRUITING

CGTBiologicstaleGuangzhou Virotech Pharmaceutic…Phase 2

Oncolytic virus VRT106 (Oncolytic virus VRT106)

Pancreatic Cancer · Pancreatic Cancer

#PancreaticCancer#CGT#Phase2#세포유전치료#CAR-T+2

ADCBiologicstaleRayzeBio, Inc.Phase 2

RYZ101 (RYZ101)

Metastatic Breast Cancer; HER2-negative Breast Cancer · HER2

ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

SGN-LIV1A (SGN-LIV1A)

Breast Neoplasms; Breast Cancer · HER2

ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

효능 ORR 34%임상시험 5상태 RECRUITING

Talazoparib plus Irinotecan (Talazoparib plus Irinotecan)

Breast Neoplasms; Breast Cancer · HER2

ADCBiologicstaleRochePhase 2

효능 ORR 0.0%임상시험 5상태 RECRUITING

trastuzumab (Herceptin, Trastuzumab emtansine [Kadcyla])

Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

효능 ORR 9.7%임상시험 5상태 ACTIVE

AntibodystaleXencor, Inc.Phase 2

Vudalimab (Vudalimab)

Ovarian Cancer; Clear Cell Carcinoma · Castration-Sensitive Prostate Carcinoma

#Castration-SensitiveProstateCarc#Antibody#Phase2#항체#면역항체+4

임상시험 5상태 DISCONTINUED

ADCBiologicstaleHoffmann-La RochePhase 2

ZN-A-1041 (ZN-A-1041)

Advanced Solid Tumors; HER2-positive Breast Cancer · HER2

ADCBiologicstaleTelix Pharmaceuticals (Innovati…Phase 1

177Lu-DOTA-TLX591 (177Lu-DOTA-TLX591)

Metastatic Prostate Cancer · Metastatic Prostate Cancer

#MetastaticProstateCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

임상시험 4상태 ACTIVE

ADCBiologicstaleTelix Pharmaceuticals (Innovati…Phase 3

177Lu-TLX591 (177Lu-TLX591)

Metastatic Castration-resistant Prostate Cancer · Metastatic Castration-resistant Prostate

#MetastaticCastration-resistantPr#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+1

ADCBiologicstaleArtiva Biotherapeutics, Inc.Phase 2

AB-201 (AB-201)

Breast Cancer; Gastric Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

임상시험 4상태 DISCONTINUED

ADCBiologicstaleMultitude Therapeutics Inc.Phase 2

AMT-116 (AMT-116)

Advanced Non-small Cell Lung Cancer (NSCLC) · Advanced Non-small Cell Lung Cancer (NSC

#AdvancedNon-smallCellLungCancerN#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

Amcenestrant + Letrozole (Amcenestrant + Letrozole)

Breast Neoplasms; Breast Cancer · HER2

#RASBRAFWild-typeAdvancedColorect#Antibody#Phase2#항체#면역항체+4

효능 ORR 42.3%임상시험 4상태 RECRUITING

AntibodyJanssenPhase 2

Amivantamab + FOLFIRI (Amivantamab + FOLFIRI)

RAS/BRAF Wild-type Advanced Colorectal Cancer Patients · RAS/BRAF Wild-type Advanced Colorectal C

ADCBiologicstaleBioNTech SEPhase 3

BNT324 (BNT324)

Advanced Lung Cancer · Metastatic Castration-resistant Prostate

#MetastaticCastration-resistantPr#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2

CGTBiologicstaleBeijing BiotechPhase 2

DLL3-CAR-NK cells (DLL3-CAR-NK cells)

Extensive Stage Lung Small Cell Cancer · SCLC, Extensive Stage

#SCLCExtensiveStage#CGT#Phase2#세포유전치료#CAR-T+3

ADCBiologicstaleFBD Biologics LimitedPhase 2

HCB101 (HCB101)

Solid Cancer · Solid Cancer

#SolidCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1